Search PubMed⌕ Search

PubMed · 14710706

The use of a positive procedure to increase engagement on-task and decrease challenging behavior.

Abstract

The exhibition of stereotypic and self-injurious behavior (SIB) combined with a lack of work engagement makes it very difficult to place a person with severe disabilities in an integrated work environment. The purpose of this research was to examine use of a positive procedure to increase engagement on-task and reduce self-injurious slapping and stereotypic clothes manipulation by a 46-year-old man with severe disabilities. A single-subject research design was used to examine the effects of the combined DRA-DRO (differential reinforcement of alternative behavior-differential reinforcement of other behavior) procedure in fostering more appropriate behavior. Following 30 years of institutionalization, the man was successfully integrated into community-based employment.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Paul L Beare, Susan Severson, Patricia Brandt. 2004. The use of a positive procedure to increase engagement on-task and decrease challenging behavior.. https://doi.org/10.1177/0145445503259217

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Choosing a behavioral therapy platform for pharmacotherapy of substance users.

Behavioral therapy platforms have become virtual requirements in pharmacotherapy trials due to their utility in reducing noise variability, preventing differential medication adherence and protocol attrition, enhancing statistical power and addressing ethical issues in placebo-controlled trials. Selecting an appropriate behavioral platform for a particular trial requires study-specific tailoring, taking into account both the stage of development of the medication being evaluated, as well as the specific strengths and weaknesses of a broad array of available empirically supported behavioral therapies and the range of their possible targets (e.g., enhancing medication adherence, preventing attrition, addressing co-morbid problems, fostering abstinence, and targeting specific weaknesses of the pharmacologic agent). Choosing a suitable behavioral platform also requires consideration of the characteristics of the population to be treated, stage of scientific knowledge regarding the medication's effects, appropriate balance of internal and external validity, and consideration of potential ceiling effects. Available manualized behavioral treatments are reviewed, noting their strengths and limitations as behavioral therapy platforms for pharmacotherapy trials and as potential concomitant therapies in clinical practice.

Behavior Therapy↗